Study links nontraditional factors to weight gain in insulin therapy

09/19/2011 | Endocrine Today

Weight gain in type 2 diabetes patients on insulin therapy was tied to various factors including higher baseline glucose rates, a lower body mass index and use of multiple insulin injection regimens, the CREDIT study revealed. Higher insulin dose at one year also was linked to more weight gain in patients, researchers reported at the European Association for the Study of Diabetes meeting.

View Full Article in:

Endocrine Today

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Site Quality Management
Minneapolis, MN
Clinical Project Manager
Abiomed, Inc.
Danvers, MA
Sr. Manager, Regulatory Affairs - International
Integra LifeSciences
Plainsboro, NJ
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
In house Compliance Officer
Pompano Beach, FL